Home LiteratureArticle Details
PMID: 16973559 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites.

Journal of virology ·Vol. 80 ·No. 19 ·2006-10-00 ·Pages 9557-68

Stiasny K, Kiermayr S, Holzmann H, Heinz FX

Abstract

A number of flaviviruses are important human pathogens, including yellow fever, dengue, West Nile, Japanese encephalitis, and tick-borne encephalitis (TBE) viruses. Infection with or immunization against any of these viruses induces a subset of antibodies that are broadly flavivirus cross-reactive but do not exhibit significant cross-neutralization. Nevertheless, these antibodies can efficiently bind to the major envelope protein (E), which is the main target of neutralizing and protective antibodies because of its receptor-binding and membrane fusion functions. The structural basis for this phenomenon is still unclear. In our studies with TBE virus, we have provided evidence that such cross-reactive antibodies are specific for a cluster of epitopes that are partially occluded in the cage-like assembly of E proteins at the surfaces of infectious virions and involve-but are not restricted to-amino acids of the highly conserved internal fusion peptide loop. Virus disintegration leads to increased accessibility of these epitopes, allowing the cross-reactive antibodies to bind with strongly increased avidity. The cryptic properties of these sites in the context of infectious virions can thus provide an explanation for the observed lack of efficient neutralizing activity of broadly cross-reactive antibodies, despite their specificity for a functionally important structural element in the E protein.

MeSH Terms
Antibody Affinity/immunology Antigens, Viral/immunology Binding Sites Cell Line Cross Reactions/immunology Enzyme-Linked Immunosorbent Assay Flavivirus/chemistry,immunology Models, Molecular Molecular Conformation Peptide Mapping Phylogeny Titrimetry Virion/chemistry,immunology
Chemicals
Antigens, Viral
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Stiasny Karin
Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria.
Kiermayr Stefan
Holzmann Heidemarie
Heinz Franz X
References (71)
71 references, click to expand
  1. Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus.
    Mol Cell. 2001 Mar;7(3):593-602 PMID: 11463384
  2. Flavivirus structure and membrane fusion.
    Adv Virus Res. 2003;59:63-97 PMID: 14696327
  3. Antigenic structure of flavivirus proteins.
    Adv Virus Res. 2003;59:141-75 PMID: 14696329
  4. Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays.
    Methods Mol Med. 2004;94:333-72 PMID: 14959839
  5. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation.
    EMBO J. 2004 Feb 25;23(4):728-38 PMID: 14963486
  6. HIV vaccine design and the neutralizing antibody problem.
    Nat Immunol. 2004 Mar;5(3):233-6 PMID: 14985706
  7. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.
    Brief Bioinform. 2004 Jun;5(2):150-63 PMID: 15260895
  8. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.
    J Immunol. 1984 Mar;132(3):1529-32 PMID: 6607288
  9. Some monoclonal antibodies raised with a native protein bind preferentially to the denatured antigen.
    Mol Immunol. 1984 Jul;21(7):673-7 PMID: 6205256
  10. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    J Gen Virol. 1985 Jul;66 ( Pt 7):1369-82 PMID: 2410549
  11. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
    J Gen Virol. 1985 Dec;66 ( Pt 12):2523-31 PMID: 2999305
  12. Epitope mapping of flavivirus glycoproteins.
    Adv Virus Res. 1986;31:103-68 PMID: 2428213
  13. Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses.
    Virology. 1988 Sep;166(1):197-205 PMID: 3413985
  14. Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH.
    Virology. 1989 Mar;169(1):90-9 PMID: 2466373
  15. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera.
    J Gen Virol. 1989 Jan;70 ( Pt 1):37-43 PMID: 2543738
  16. The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization.
    J Virol. 1991 Oct;65(10):5579-83 PMID: 1716695
  17. Caveats for the use of surface-adsorbed protein antigen to test the specificity of antibodies.
    J Immunol Methods. 1992 Feb 14;147(1):125-34 PMID: 1311735
  18. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
    J Immunol. 1993 Nov 15;151(10):5408-15 PMID: 7693811
  19. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM.
    Virology. 1994 Jan;198(1):109-17 PMID: 8259646
  20. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
    Virology. 1994 Sep;203(2):241-9 PMID: 8053148
  21. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
    Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 PMID: 7984417
  22. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH.
    J Virol. 1995 Feb;69(2):695-700 PMID: 7529335
  23. Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions.
    Arch Virol. 1995;140(2):213-21 PMID: 7535997
  24. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.
    Nature. 1995 May 25;375(6529):291-8 PMID: 7753193
  25. [A highly-productive attenuated variant of Japanese encephalitis virus].
    Vopr Virusol. 1995 Nov-Dec;40(6):265-8 PMID: 8686263
  26. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions.
    J Virol. 1996 Jul;70(7):4549-57 PMID: 8676481
  27. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    J Med Virol. 1996 Jan;48(1):102-7 PMID: 8825718
  28. HIV-1 antibody--debris or virion?
    Nat Med. 1997 Apr;3(4):366-7 PMID: 9095159
  29. Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.
    J Virol. 1998 May;72(5):3512-9 PMID: 9557629
  30. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Virology. 1998 Jul 5;246(2):317-28 PMID: 9657950
  31. Mathematical model of a virus-neutralizing immunglobulin response.
    J Theor Biol. 1998 Nov 7;195(1):41-52 PMID: 9802949
  32. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.
    J Virol. 1999 Apr;73(4):2956-62 PMID: 10074145
  33. Conformational changes of the flavivirus E glycoprotein.
    Structure. 2004 Sep;12(9):1607-18 PMID: 15341726
  34. The flaviviruses (group B arboviruses): a cross-neutralization study.
    J Gen Virol. 1974 Apr;23(1):91-6 PMID: 4833603
  35. The basis of arbovirus classification.
    Med Biol. 1975 Oct;53(5):400-5 PMID: 1207193
  36. Antibody-mediated destruction of virus-infected cells.
    Adv Immunol. 1980;29:209-60 PMID: 6251708
  37. Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses.
    J Gen Virol. 1981 Dec;57(Pt 2):263-74 PMID: 6172553
  38. Monoclonal antibodies against the flavivirus West Nile.
    J Gen Virol. 1982 Feb;58(Pt 2):283-9 PMID: 7061990
  39. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.
    Am J Trop Med Hyg. 1982 May;31(3 Pt 1):548-55 PMID: 6177259
  40. Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies.
    J Gen Virol. 1982 Nov;63 (Pt 1):237-40 PMID: 6294229
  41. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies.
    Virology. 1983 Jul 15;128(1):118-26 PMID: 6192585
  42. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.
    Am J Trop Med Hyg. 1958 Sep;7(5):561-73 PMID: 13571577
  43. The regulation and maturation of antiviral immune responses.
    Adv Virus Res. 2004;63:181-238 PMID: 15530562
  44. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
    J Virol. 2004 Dec;78(23):12910-8 PMID: 15542643
  45. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
    J Virol. 2004 Dec;78(23):12919-28 PMID: 15542644
  46. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes.
    J Virol. 2004 Dec;78(24):13975-86 PMID: 15564505
  47. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses.
    Nat Med. 2004 Dec;10(12 Suppl):S98-109 PMID: 15577938
  48. A structural perspective of the flavivirus life cycle.
    Nat Rev Microbiol. 2005 Jan;3(1):13-22 PMID: 15608696
  49. The many mechanisms of viral membrane fusion proteins.
    Curr Top Microbiol Immunol. 2005;285:25-66 PMID: 15609500
  50. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.
    J Virol. 2005 Jan;79(2):1223-31 PMID: 15613349
  51. Class I and class II viral fusion protein structures reveal similar principles in membrane fusion.
    Mol Membr Biol. 2004 Nov-Dec;21(6):361-71 PMID: 15764366
  52. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.
    J Virol. 2005 Jul;79(13):8339-47 PMID: 15956579
  53. Mechanism of membrane fusion by viral envelope proteins.
    Adv Virus Res. 2005;64:231-61 PMID: 16139596
  54. Structural basis of West Nile virus neutralization by a therapeutic antibody.
    Nature. 2005 Sep 29;437(7059):764-9 PMID: 16193056
  55. Virus membrane-fusion proteins: more than one way to make a hairpin.
    Nat Rev Microbiol. 2006 Jan;4(1):67-76 PMID: 16357862
  56. Antiviral antibody responses: the two extremes of a wide spectrum.
    Nat Rev Immunol. 2006 Mar;6(3):231-43 PMID: 16498452
  57. Monoclonal antibodies to the structural glycoprotein of tick-borne encephalitis virus.
    Infect Immun. 1982 Sep;37(3):869-74 PMID: 6182103
  58. Dengue and other emerging flaviviruses.
    J Infect. 2001 Feb;42(2):104-15 PMID: 11531316
  59. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.
    Cell. 2002 Mar 8;108(5):717-25 PMID: 11893341
  60. Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH.
    J Virol. 2002 Apr;76(8):3784-90 PMID: 11907218
  61. HIV vaccine strategies.
    Vaccine. 2002 May 6;20(15):1945-7 PMID: 11983251
  62. A ligand-binding pocket in the dengue virus envelope glycoprotein.
    Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6986-91 PMID: 12759475
  63. Structure of West Nile virus.
    Science. 2003 Oct 10;302(5643):248 PMID: 14551429
  64. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus.
    Nat Struct Biol. 2003 Nov;10(11):907-12 PMID: 14528291
  65. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.
    Science. 1999 Dec 17;286(5448):2333-7 PMID: 10600742
  66. Antibodies in human infectious disease.
    Immunol Res. 2000;21(2-3):265-78 PMID: 10852127
  67. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
    AIDS. 1999;13 Suppl A:S137-62 PMID: 10885772
  68. Infection of human cells by dengue virus is modulated by different cell types and viral strains.
    J Virol. 2000 Sep;74(17):7814-23 PMID: 10933688
  69. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Annu Rev Biochem. 2000;69:531-69 PMID: 10966468
  70. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.
    J Virol. 2001 May;75(9):4268-75 PMID: 11287576
  71. A model for neutralization of viruses based on antibody coating of the virion surface.
    Curr Top Microbiol Immunol. 2001;260:109-43 PMID: 11443871
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2006-10-00
Pages
9557-68
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1617264
Subset
IM
Grants
Austrian Science Fund FWF · P 17035 · Austria
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com